Showing results (151-160 of 479) with videos related to

Sort By:
Pageof 48
The Journal of Infectious Diseases|March 18, 2006
Identification of a novel single-stranded DNA fragment associated with human hepatitisChau-Ting Yeh, Mei-Lin Tsao, Ying-Chun Lin, et al.
Hepatology International|August 12, 2009
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up studyYi-Cheng Chen, Chia-Ming Chu, Chau-Ting Yeh, et al.
World Journal of Gastroenterology|July 15, 2005
Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligationMing-Ling Chang, Chau-Ting Yeh, Pei-Yeh Chang, et al.
The Journal of Infectious Diseases|October 29, 2008
Impact of the novel hepatotropic viruslike agent NV-F during chronic hepatitis C virus infectionChau-Ting Yeh, Chao-Wei Hsu, Ming-Ling Chang, et al.
Biochemical and Biophysical Research Communications|May 15, 2003
Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutantChau-Ting Yeh, Su-Chuan Lu, Chung-Hao Chao, et al.
Biochemical and Biophysical Research Communications|September 8, 2004
Anti-sense expression of a metallopeptidase gene enhances nuclear entry of HBV-DNAChau-Ting Yeh, Hsin-Yu Lai, Shiou-Ping Chu, et al.
Journal of Hepatology|May 18, 2005
Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis BMing-Ling Chang, Rong-Nan Chien, Chau-Ting Yeh, et al.
In Vivo (Athens, Greece)|June 25, 2018
Increase of Serum Kallikrein-8 Level After Long-term Telbivudine TreatmentHaw-En Wang, Chih-Lang Lin, Tai-Long Pan, et al.
Biochemical and Biophysical Research Communications|May 14, 2008
Hepatitis C virus infection in mouse hepatoma cells co-expressing human CD81 and Sip-LChau-Ting Yeh, Hsin-Yu Lai, Yung-Ju Yeh, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 20, 2009
Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppressionChau-Ting Yeh, Chao-Wei Hsu, Yi-Cheng Chen, et al.
Pageof 48